Long-Term Impact of the Coronavirus Disease 2019 Pandemic on Children with Eosinophilic Esophagitis
Authors:
- Sinem Polat Terece 1S1Sinem Polat Terece 1
- Hacer İlBilge Ertoy Karagöl 1H1Hacer İlBilge Ertoy Karagöl 1
- Gizem Köken 1G1Gizem Köken 1
- Dilek Yapar 2D2Dilek Yapar 2
- Hakan Öztürk 2H2Hakan Öztürk 2
- Demet Teker Düztaş 2D2Demet Teker Düztaş 2
- Ödül Eğritaş Gürkan 2Ö2Ödül Eğritaş Gürkan 2
- Sinan Sarı 2S2Sinan Sarı 2
- Buket Dalgıç 2B2Buket Dalgıç 2
- Arzu Bakırtaş 1A1Arzu Bakırtaş 1
Open Access
- 1 September 2025
- journal article
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 60 (5) , 524-530
Abstract
Objective: Although a limited number of studies have assessed the impact of the Coronavirus disease 2019 (COVID-19) pandemic on adults with eosinophilic esophagitis (EoE), there are no data on children. This study aimed to assess the impact of the COVID-19 pandemic on children with EoE, including long-term follow-up, treatment adherence, COVID-19 infection, and vaccination status. Materials and Methods: Treatment adherence, symptoms, and endoscopic-pathological findings were compared at the beginning and the end of the first and second years of the pandemic. The COVID-19 infection and vaccination status were also assessed. Results: The study included 66 children (median age 13.2 years) with EoE. Both treatment adherence and endoscopic follow-up decreased significantly during the pandemic compared to the beginning (P < .001 and P < .001, respectively). No strictures were observed. Twentytwo patients underwent endoscopy both before and during the pandemic, showing increased total eosinophilic esophagitis endoscopic reference score (EREFS) and peak eosinophil counts (P = .045 and P = .08, respectively). Among children aged 12 and older, 66% were vaccinated against COVID-19. Infection with COVID-19 was detected in 24 children (36.3%), with asymptomatic or mild symptoms in 95.8% of cases. Conclusion: No strictures developed during the first 2 years of the pandemic in children with EoE. However, increased tissue eosinophilia and EREFS scores suggest a possible risk of fibrostenosis if treatment adherence remains low. Eosinophilic esophagitis does not seem to pose an increased risk for COVID-19 infection in children. Cite this article as: Polat Terece S, Ertoy Karagöl HI, Köken G, et al. Long-term impact of the Coronavirus disease 2019 pandemic on children with eosinophilic esophagitis. Turk Arch Pediatr. 2025;60(5):524-530.Keywords
This publication has 26 references indexed in Scilit:
- Primary Eosinophilic Gastrointestinal Diseases Beyond Eosinophilic Esophagitis in ChildrenJournal of Pediatric Gastroenterology and Nutrition, 2021
- Changes in Health Services Use Among Commercially Insured US Populations During the COVID-19 PandemicJAMA Network Open, 2020
- Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 OutbreakJournal of Clinical Medicine, 2020
- Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic periodThe Lancet Gastroenterology & Hepatology, 2020
- Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophagesNature Reviews Immunology, 2020
- Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: A 12-year population-based studyDigestive and Liver Disease, 2019
- Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent MannerGastroenterology, 2013
- Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading systemGut, 2012
- Factors Associated With Non-Adherence to Oral Medication for Inflammatory Bowel Disease: A Systematic ReviewAmerican Journal of Gastroenterology, 2010
- Medication Adherence in Pediatric Asthma: Reasoning, Responsibility, and BehaviorJournal of Pediatric Psychology, 2003